GULF PHARMACEUTICAL INDUSTRIES GPHI.AD :
* FY NET LOSS 153 MILLION DIRHAMS
* FY NET SALES 863 MILLION DIRHAMS
* DECLINE IN REVENUE AND PROFITABILITY DUE TO THE HEADWINDS IN SAUDI ARABIA
* IN 2019, CHALLENGES STILL LIE AHEAD BUT WE ARE TAKING STEPS TO STRENGTHEN OUR FINANCIAL HEALTH"
* AS WE ASSESSED IMPLICATIONS OF VARIOUS FACTORS ON OUR BUSINESS, WE MADE DIFFICULT DECISION THAT WORKFORCE REDUCTIONS WERE NECESSARY"
Source:(https://bit.ly/2NleoBr) Further company coverage: GPHI.AD
((Reuters.Briefs@thomsonreuters.com;))
